Answers are grounded in this paper and cite their sources.
Abstract NS1 binding protein (NS1-BP), a non-structural NS1-binding protein of influenza A virus, regulates viral or host RNA processing/export, cancer progression, or neurite/dendritic spine regulation. However, its precise roles in stress-induced responses without viral infection are largely unknown. Therefore, this study aims to investigate the novel roles of NS1-BP, which interact with GABARAP subfamily proteins, including LC3-interacting region-containing proteins, in regulating stress granules (SGs) during oxidative stress. NS1-BP interacts with core SG components and localizes to GABARAP-containing SGs during oxidative stress. Moreover, it associates with p62, acting as an adaptor for selective autophagy via its Kelch-motif and ubiquitin-associated domain in p62 in a stress-dependent manner. NS1-BP knockout (KO) HeLa cells demonstrated altered SG dynamics, mirroring observation in p62 KO or GABARAP triple KO cells, indicating impaired autophagic SG degradation. NS1-BP KO cells, compared to wild-type (WT) cells, showed increased p62 ubiquitination, leading to autophagic p62 degradation, while NS1-BP overexpression reduces p62 ubiquitination. In NS1-BP KO cells, overexpression of p62 WT, not p62 K420R or K435R, restored SGs size and number. Additionally, amyotrophic lateral sclerosis (ALS)-induced pluripotent stem cell-derived motor neurons showed reduced NS1-BP levels, resulting in SG morphology dysregulation. Our findings reveal the novel role of NS1-BP in negatively regulating p62 ubiquitination, influencing SG dynamics and clearance during oxidative stress. This highlights its relevance to ALS pathogenesis associated with SGs.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: